Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to -$418000.0.

  • MediWound's Depreciation & Amortization (CF) fell 1578.95% to -$418000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$63000.0, marking a year-over-year decrease of 45000.0%. This contributed to the annual value of -$1.5 million for FY2024, which is 21381.43% down from last year.
  • According to the latest figures from Q3 2025, MediWound's Depreciation & Amortization (CF) is -$418000.0, which was down 1578.95% from $394000.0 recorded in Q2 2025.
  • In the past 5 years, MediWound's Depreciation & Amortization (CF) ranged from a high of $394000.0 in Q2 2025 and a low of -$418000.0 during Q3 2025
  • In the last 5 years, MediWound's Depreciation & Amortization (CF) had a median value of $315000.0 in 2023 and averaged $82368.4.
  • Per our database at Business Quant, MediWound's Depreciation & Amortization (CF) plummeted by 22321.43% in 2021 and then soared by 20289.86% in 2022.
  • Quarter analysis of 5 years shows MediWound's Depreciation & Amortization (CF) stood at -$276000.0 in 2021, then skyrocketed by 202.9% to $284000.0 in 2022, then tumbled by 221.83% to -$346000.0 in 2023, then decreased by 14.74% to -$397000.0 in 2024, then dropped by 5.29% to -$418000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at -$418000.0 for Q3 2025, versus $394000.0 for Q2 2025 and $358000.0 for Q1 2025.